Strand Therapeutics
Kinnevik Stake
7%
Building the next era of genetic medicine
Business overview
Strand is a clinical-stage biotechnology company with a pipeline of breakthrough mRNA therapeutics for cancers and autoimmune diseases.
Solving the biggest problems in genetic medicine to build plug-and-play delivery systems that bring therapies to vastly more patients and indications.
